Case report: A novel variant (H49N) in Myelin Protein Zero gene is responsible for a patient with Charcot–Marie–Tooth disease

Gao-Hui Cao,Mei-Fang Zhao,Yi Dong,Liang-Liang Fan,Yi-Hui Liu,Yao Deng,Lu-Lu Tang
DOI: https://doi.org/10.3389/fneur.2024.1319962
IF: 3.4
2024-02-29
Frontiers in Neurology
Abstract:This report presents a case of Charcot–Marie–Tooth dominant intermediate D (CMTDID), a rare subtype of Charcot–Marie–Tooth disease, in a 52 years-old male patient. The patient exhibited mobility impairment, foot abnormalities (pes cavus), and calf muscle atrophy. Whole exome sequencing and Sanger sequencing suggested that a novel variant (NM_000530.8, c.145C>A/p.His49Asn) of MPZ may be the genetic lesion in the patient. The bioinformatic program predicted that the new variant (p.His49Asn), located at an evolutionarily conserved site of MPZ , was neutral. Our study expands the variant spectrum of MPZ and the number of identified CMTDID patients, contributing to a better understanding of the relationship between MPZ and CMTDID.
neurosciences,clinical neurology
What problem does this paper attempt to address?